Radioisotopes for the palliation of metastatic bone cancer: a systematic review
Radioisotopes for the palliation of metastatic bone cancer: a systematic review
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Strontium-89 and samarium-153 are radioisotopes that are approved in the USA and Europe for the palliation of pain from metastatic bone cancer, whereas rhenium-186 and rhenium-188 are investigational. Radioisotopes are effective in providing pain relief with response rates of between 40% and 95%. Pain relief starts 1–4 weeks after the initiation of...
Alternative Titles
Full title
Radioisotopes for the palliation of metastatic bone cancer: a systematic review
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_200899350
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_200899350
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(05)70206-0
